AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger.
Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pa
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P.

New Strong Sell Stocks for January 6th

06:16am, Tuesday, 06'th Jan 2026
AVNS, ALG and CLMB have been added to the Zacks Rank #5 (Strong Sell) List on January 6th, 2026.
Avanos Medical (NYSE: AVNS - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the
Squarepoint Ops LLC purchased a new stake in Avanos Medical, Inc. (NYSE: AVNS) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Co

New Strong Sell Stocks for Dec. 17

07:11am, Wednesday, 17'th Dec 2025
AVNS, ADM and OZK have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 17, 2025.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Envestnet Asset Management Inc. raised its position in shares of Avanos Medical, Inc. (NYSE: AVNS) by 45.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 210,
Inspira Technologies OXY B.H.N. (NASDAQ: IINN - Get Free Report) and Avanos Medical (NYSE: AVNS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare
Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.
Avanos Medical, Inc. ( AVNS ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Jason Pickett - Vice President of Tax & Treasurer David Pacitti - CEO & Director Scott Galovan - C
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.36 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE